Insider Monkey (blog) | Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): This Company Is ... Insider Monkey (blog) In protein based therapy, Lemtrada competes with late stage therapeutic candidates such as Daclizumab, Rituximab, and Ofatumumab. Daclizumab is a monoclonal antibody. It is developed by Biogen Idec Inc. (NASDAQ:BIIB) in collaboration with Abbott ... |
